Pharmacy

Becker’s asked pharmacy executives from hospitals and health systems across the U.S. to share their top priorities for the rest of 2025. The 12 executives featured in this article are all speaking at the Becker’s Healthcare Fall Chief Pharmacy Officer…

A federal judge has temporarily blocked portions of Iowa’s pharmacy benefit manager law, Senate File 383, ruling that several provisions likely conflict with federal law, the Des Moines Register reported July 22.  Here are three notes: 

Lawmakers in the House and Senate introduced legislation this week that could prohibit pharmaceutical companies from restricting access to 340B drug pricing discounts.  The Pharmaceutical Access to Invest in Essential, Needed Treatments & Support Act, introduced by Rep. Doris Matsui…

After reaching a record high in 2024, the number of active drug shortages is declining, according to a recent American Society of Health-System Pharmacists report. However, while new shortages have slowed, many hospitals and health systems continue to face challenges…

Sarepta will stop shipping its Duchenne muscular dystrophy gene therapy Elevidys following ongoing discussions with the FDA over safety labeling.  The drugmaker said the pause, effective July 22, will allow time to respond to FDA inquiries and complete the agency’s…

Here are nine new drug shortages and discontinuations, according to drug supply databases from the FDA and the American Society of Health-System Pharmacists. 

A combination of two cancer drugs may provide a pathway to treat Alzheimer’s, according to a study published July 21 in Cell.  Researchers from the University of California San Francisco developed and applied a computational drug repurposing algorithm to 1,300…

Ninety-three percent of hospitals responding to a recent survey conducted by 340B Health said they would struggle to maintain current levels of uncompensated care in the wake of drugmakers’ proposed rebate plan changes with respect to the federal 340B pricing…

From cell-manufacturing laboratories to outpatient infusion facilities, health systems are rapidly adapting to a new kind of cancer treatment that demands individualized care, infrastructure and training: immunotherapy.  To better navigate the complex and strategic considerations presented by immunotherapy, healthcare leaders…

With hundreds of drug shortages persisting across the U.S., pharmacy leaders are adopting more coordinated strategies to manage supply disruptions and mitigate financial losses. These include expanding on-hand inventory for critical injectable medications, centralizing supply chain operations and embedding clinical…